首页>
外国专利>
PHARMACEUTICAL COMPOSITION FOR TREATING APLASTIC ANEMIA
PHARMACEUTICAL COMPOSITION FOR TREATING APLASTIC ANEMIA
展开▼
机译:用于治疗血栓性贫血的药物组合物
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to a pharmaceutical composition for treating aplastic anemia, which comprises Romiplostim as an active ingredient, wherein the pharmaceutical composition is administered subcutaneously once a week, wherein Romiplostim is administered at 10 µg/kg/week for 4 weeks from the start of administration, administered at more than 10 µg/kg/week and at a maximum of 20 µg/kg/week after week 5.
展开▼
机译:本发明涉及用于治疗制备障碍贫血的药物组合物,其包括作为活性成分的ROMIPlosim,其中药物组合物每周皮下给药一次,其中romiplosim以10μg/ kg /周施用4周,从开始时4周施用4周 给药,在超过10μg/ kg /周,每周50μg/ kg /周最多施用。
展开▼